Product Review

Product Update: MyoSure MANUAL; Rivanna's Accuro 3D; PeriGen; Instavit


 

HYSTEROSCOPY TISSUE REMOVAL DEVICE

Hologic, Inc, has introduced the MyoSure® MANUAL Tissue Removal Device for resecting and removing tissue during in-office hysteroscopic intrauterine procedures. When used with the MyoSure hysteroscope, the MyoSure MANUAL device has a fully integrated vacuum that does not require external suction and can be operated using a 1-L saline bag. The clear tissue trap allows for visual confirmation of removed tissue, holds up to 4 g of tissue, and detaches to send the specimen to pathology. Hologic says that the MyoSure MANUAL gives physicians multifunction control of the 360° blade for removal of tissue, including fibroids and polyps. The MyoSure Manual is a sterile, nonpowered, hand-actuated, single-use device.

This new Hologic product joins the MyoSure suite of gynecologic surgical products that includes the MyoSure, MyoSure REACH, MyoSure XL, and MyoSure LITE devices.

FOR MORE INFORMATION, VISIT: http://myosure.com/

SPINAL NAVIGATION TECHNOLOGY FOR EPIDURAL ANESTHESIA

The Accuro® 3D image-guided spinal navigation technology by Rivanna Medical® is a handheld, lightweight, untethered ultrasound-based system designed to help apply spinal and epidural anesthesia. Ultrasonography is the imaging modality of choice for epidurals in expectant mothers who must avoid the radiation involved in other imaging procedures, according to Rivanna Medical.

In a recent trial, Accuro identified the appropriate epidural injection sites along the lower spine and calculated the depth to the epidural space. Actual epidural depth was confirmed by measuring needle penetration during successful epidural delivery by anesthesia providers. Accuro predicted this depth within an average of 0.61 cm, reports Rivanna Medical. In addition, Accuro identified the appropriate spinal interspace for needle insertion in 94% of patients and enabled 87% success in first-attempt epidural administration.

FOR MORE INFORMATION, VISIT: https://rivannamedical.com/

SOFTWARE AND HUB HELP IDENTIFY CRITICALLY ILL L&D PATIENTS

PeriGen, Inc, a software-solutions company, has launched PeriWatch HUB™, new perinatal software and a dashboard for labor and delivery (L&D) units.

PeriGen says that its PeriWatch modules provide state-of-the-art L&D documentation and fetal surveillance coupled with analytics and an electronic critical-condition dashboard for hospital maternity units.

HUB is an intelligent perinatal dashboard designed to facilitate the timely recognition of maternity patients who develop critical illness. Using PeriGen’s proprietary algorithms, it prioritizes patients based on physician-chosen threshold settings for vital signs, labor progress, and fetal heart rate patterns, and consolidates that data into an easy-to-read interactive dashboard.

FOR MORE INFORMATION, VISIT: http://perigen.com/

ORAL SPRAY VITAMINS: ALTERNATIVE TO PILLS

Instavit® Spray Vitamins offer an alternative to patients who have difficulty swallowing pills. Instavit says that its oral vitamins, sprayed directly into the mouth, are sugar-free, tasty, gluten-free, and contain zero calories. The sprays are manufactured to the highest standard in cGMP, FDA approved facilities in the United States. Each Instavit spray provides an exact and measured amount of liquid, allowing for correct dosing and also permitting individualization of intake. A 14-oz spray bottle contains about 28 doses.

The Instavit line includes: “Prenatal Care,” “Vitamin B12,” “Instant Energy,” “Vitamin D,” “Daily Health,” “Sweet Dreams,” “Immune Strength,” “Clearer Thinking,” and “Instavit for Kids.” Instavit products are available in retail stores in North America.

FOR MORE INFORMATION, VISIT: http://www.instavit.com/

Share your thoughts! Send your Letter to the Editor to rbarbieri@frontlinemedcom.com. Please include your name and the city and state in which you practice.

Next Article:

   Comments ()

Recommended for You

Reviews and Expert Commentary

Quizzes from MD-IQ

Research Summaries from ClinicalEdge